BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12395089)

  • 1. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
    Lo AC; Black JA; Waxman SG
    Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
    Black JA; Liu S; Hains BC; Saab CY; Waxman SG
    Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
    Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
    Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
    Black JA; Waxman SG
    J Neurol Sci; 2008 Nov; 274(1-2):57-63. PubMed ID: 18485368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
    Black JA; Liu S; Carrithers M; Carrithers LM; Waxman SG
    Ann Neurol; 2007 Jul; 62(1):21-33. PubMed ID: 17654737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
    Lo AC; Saab CY; Black JA; Waxman SG
    J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
    Vergo S; Craner MJ; Etzensperger R; Attfield K; Friese MA; Newcombe J; Esiri M; Fugger L
    Brain; 2011 Feb; 134(Pt 2):571-84. PubMed ID: 21233144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE.
    Craner MJ; Hains BC; Lo AC; Black JA; Waxman SG
    Brain; 2004 Feb; 127(Pt 2):294-303. PubMed ID: 14662515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination.
    Craner MJ; Lo AC; Black JA; Waxman SG
    Brain; 2003 Jul; 126(Pt 7):1552-61. PubMed ID: 12805113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI.
    Hains BC; Saab CY; Lo AC; Waxman SG
    Exp Neurol; 2004 Aug; 188(2):365-77. PubMed ID: 15246836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
    Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
    J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal protection using flecainide in experimental autoimmune encephalomyelitis.
    Bechtold DA; Kapoor R; Smith KJ
    Ann Neurol; 2004 May; 55(5):607-16. PubMed ID: 15122700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.
    O'Malley HA; Shreiner AB; Chen GH; Huffnagle GB; Isom LL
    Mol Cell Neurosci; 2009 Feb; 40(2):143-55. PubMed ID: 19013247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
    Liu S; Zwinger P; Black JA; Waxman SG
    J Neurol Sci; 2014 Jun; 341(1-2):8-12. PubMed ID: 24690348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis.
    Stevens M; Timmermans S; Bottelbergs A; Hendriks JJ; Brône B; Baes M; Tytgat J
    J Neuroimmunol; 2013 Aug; 261(1-2):21-8. PubMed ID: 23735284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve.
    Garthwaite G; Goodwin DA; Batchelor AM; Leeming K; Garthwaite J
    Neuroscience; 2002; 109(1):145-55. PubMed ID: 11784706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.